Elicio Therapeutics (ELTX) Interest & Investment Income (2022 - 2026)
Elicio Therapeutics (ELTX) reported Interest & Investment Income of $157000.0 for Q1 2026, down 25.24% on a YoY basis from $210000.0 in Q1 2025, and down 21.11% quarter-over-quarter from $199000.0 in Q3 2025.
Elicio Therapeutics (ELTX) Interest & Investment Income (2022 - 2026) Analysis & Trends
Elicio Therapeutics has reported Interest & Investment Income for 5 years, with the latest figure at $157000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 25.24% year-over-year to $157000.0; the trailing twelve-month figure through Mar 2026 stood at $734000.0 (up 7.62% YoY), and the FY2023 full-year result was $373000.0, up 473.85% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $157000.0, down from $199000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $246000.0 in Q3 2023, with the low at $10000.0 in Q3 2022.
- Historically, Interest & Investment Income has averaged $126230.8 across 5 years, with a median of $150000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 2360.0% — and 2026, when it fell 25.24%.
- Elicio Therapeutics' Interest & Investment Income stood at $55000.0 in 2022, then soared by 36.36% to $75000.0 in 2023, then soared by 146.67% to $185000.0 in 2024, then gained by 7.57% to $199000.0 in 2025, then slipped by 21.11% to $157000.0 in 2026.
- The last three Interest & Investment Income figures came in at $157000.0 (Q1 2026), $199000.0 (Q3 2025), and $168000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 210,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 246,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 10,000.00 |